Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6195)
  2. Meeting Abstract (6166)
  3. Review (401)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (160)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11094)
  2. Hematologic Malignancies, Division of (10645)
  3. GSK Faculty (5449)
  4. Adult Leukemia (3723)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (946)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (317)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (268)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1669)
  3. Nature Publishing Group (1118)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of an anti-CD30 x anti-CD16A bispecific tandab antibody, AFM13, in patients with relapsed or refractory Hodgkin lymphoma
    Meeting Abstract

    Zhukovsky, E.; Rothe, A.; von Tresckow, B.; Topp, M.; Younes, A.; Eichenauer, D. A.; Hummel, H.; Reiners, K. S.; Dietlein, M.; Kessler, J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Arginine methylation of RBM15 by PRMT1 controls alternative splicing of genes involved in megakaryocyte differentiation
    Meeting Abstract

    Zhao, X.; Zhang, L.; Wang, R.; Trans, N. T.; Su, H.; Abdel-Wahab, O.; Hrick, T.; Levine, R. L.; Deng, H.; Liu, Y.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Increased incidence of melanoma and non-melanoma skin cancers in patients with hairy cell leukemia: A single institution experience with 267 patients from Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Watts, J. M.; Kishtagari, A.; Devlin, S.; Stein, E. M.; Park, J. H.; Lacouture, M. E.; Tallman, M.
    Blood (2013)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation is effective in patients with advanced systemic mastocytosis: A multicenter retrospective analysis
    Meeting Abstract

    Ustun, C.; Reiter, A.; Scott, B. L.; Nakamura, R.; Gandhi, D.; Kreil, S.; Shanley, R.; Hogan, W. J.; Perales, M. A.; Shore, T. B.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Sex steroid blockade enhances thymopoiesis by modulating notch signaling
    Meeting Abstract

    Velardi, E.; Tsai, J. J.; Holland, A. M.; Singer, N. V.; West, M. L.; Smith, O. M.; Young, L. F.; Kreines, F. M.; Levy, E. R.; Boyd, R.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • A phase 1/2 study of blinatumomab in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Meeting Abstract

    von Stackelberd, A.; Zugmaier, G.; Handgretinger, R.; Locatelli, F.; Rizzari, C.; Trippett, T. M.; Borkhardt, A.; Rheingold, S. R.; Bader, P.; Bhojwani, D.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Influence of killer immunoglobulin-like receptor (KIR) and HLA genotypes on outcomes after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation for patients with AML and MDS: A report from the Center For International Blood and Marrow Transplant Research Immunobiology Working Committee
    Meeting Abstract

    Sobecks, R. M.; Gallagher, M. M.; Askar, M.; Haagenson, M. D.; Wang, T.; Spellman, S.; Lee, S. J.; Fernandez Viña, M. A.; Muller, C. R.; Verneris, M. R.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Adverse cytogenetic abnormalities at diagnosis are the most important predictor of relapse post T cell depleted (TCD) allogeneic hematopoietic stem cell transplantation in patients with advanced myelodysplastic syndrome (MDS)
    Meeting Abstract

    Tamari, R.; Jakubowski, A. A.; Papadopoulos, E. B.; Giralt, S. A.; Goldberg, J. D.; Ponce, D. M.; Sauter, C. S.; Hilden, P.; Devlin, S.; Young, J. W.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Targeting metabolic inputs into epigenetic regulations of acute leukemia
    Meeting Abstract

    Thompson, C. B.
    Blood (2013)

    Fulltext@MSK | Save
  • A prospective multicenter study of the Bruton's tyrosine kinase inhibitor ibrutinib in patients with relapsed or refractory Waldenstrom's macroglobulinemia
    Meeting Abstract

    Treon, S. P.; Tripsas, C. K.; Yang, G.; Cao, Y.; Xu, L.; Hunter, Z.; Cropper, S. J.; Mostyn, P.; Meid, K.; Warren, D.; more...
    Blood (2013)

    Fulltext@MSK | Save